Molecular Imaging in the Head and Neck: Diagnosis and Therapy.

Journal Article (Journal Article;Review)

This article is a summary of the most up-to-date applications of radiopharmaceuticals to the diagnosis and therapy of benign and malignant diseases involving endocrine or neuroendocrine organs of the head and neck, focusing on radiotracers approved by the US Food and Drug Administration, such as I-123- and I-131-sodium iodide, F-18-fluorodeoxyglucose, Tc99m-sestamibi, as well as the more recently approved tracers Ga-68 DOTATATE and Lu-177 DOTATATE.

Full Text

Duke Authors

Cited Authors

  • Howard, BA

Published Date

  • November 2020

Published In

Volume / Issue

  • 58 / 6

Start / End Page

  • 1135 - 1146

PubMed ID

  • 33040853

Pubmed Central ID

  • 33040853

Electronic International Standard Serial Number (EISSN)

  • 1557-8275

Digital Object Identifier (DOI)

  • 10.1016/j.rcl.2020.08.001

Language

  • eng

Conference Location

  • United States